India to get Novo Nordisk’s Ozempic soon as demand for obesity drugs surges (Soban News)

Novo Nordisk’s Ozempic launch adds to its GLP-1 portfolio, offering patients new options while competing with Eli Lilly’s Mounjaro in India​Novo Nordisk’s Ozempic launch adds to its GLP-1 portfolio, offering patients new options while competing with Eli Lilly’s Mounjaro in India ​Latest News [ SOBAN NEWS: International and National ]